Diabetes associated with immune checkpoint inhibition: presentation and management challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diabetes associated with immune checkpoint inhibition: presentation and management challenges

Published:2018-08-07 Issue:9 Volume:35 Page:1283-1290
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Galligan A.¹^ORCID,Xu W.²,Fourlanos S.¹,Nankervis A.¹,Chiang C.¹²,Mant A. M.³,Parente P.³,Rischin D.²⁴,Krishnamurthy B.⁵,Sandhu S.²⁴,Colman P. G.¹²

Affiliation:

1. Department of Diabetes and Endocrinology; Royal Melbourne Hospital; Melbourne Australia

2. Division of Cancer Medicine; Peter MacCallum Cancer Centre; Melbourne Australia

3. Cancer Services, Eastern Health; Monash University; Melbourne Australia

4. Sir Peter MacCallum; Department of Oncology; University of Melbourne; Melbourne Australia

5. St Vincent's Institute; Melbourne Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13762/fullpdf

Reference41 articles.

1. Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies;Byun;Nat Rev Endocrinol,2017

2. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

4. Pembrolizumab versus Ipilimumab in Advanced Melanoma;Robert;N Engl J Med,2015

5. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature;Frontiers in Immunology;2024-04-18

2. A Case in Which HLA-DR4 is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events following Combination Therapy with Nivolumab and Ipilimumab;Case Reports in Endocrinology;2024-03-22

3. Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes;Proceedings of the National Academy of Sciences;2024-01-29

4. Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care;Clinical Therapeutics;2024-01

5. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus;International Immunopharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3